# A Safety and Efficacy Study of NAC in Patients With TA-TMA

> **NCT03252925** · PHASE3 · COMPLETED · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 170 (actual)

## Conditions studied

- Thrombotic Microangiopathies
- Hematologic Diseases

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03252925
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252925, "A Safety and Efficacy Study of NAC in Patients With TA-TMA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03252925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*